| __timestamp | Regeneron Pharmaceuticals, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2819557000 | 152381 |
| Thursday, January 1, 2015 | 4103728000 | 152381 |
| Friday, January 1, 2016 | 4860427000 | 152381 |
| Sunday, January 1, 2017 | 5872227000 | 152381 |
| Monday, January 1, 2018 | 6710800000 | 152000 |
| Tuesday, January 1, 2019 | 7863400000 | 152000 |
| Wednesday, January 1, 2020 | 8497100000 | 152000 |
| Friday, January 1, 2021 | 16071700000 | 6689000 |
| Saturday, January 1, 2022 | 12172900000 | 2785000 |
| Sunday, January 1, 2023 | 13117200000 | 233662000 |
| Monday, January 1, 2024 | 14202000000 |
Unleashing the power of data
In the dynamic world of biotechnology, revenue trends offer a window into a company's growth and market impact. Over the past decade, Regeneron Pharmaceuticals, Inc. has demonstrated a remarkable revenue trajectory, growing from approximately $2.8 billion in 2014 to over $13 billion in 2023. This represents an impressive increase of nearly 360%, underscoring Regeneron's robust market presence and successful product pipeline.
Conversely, TG Therapeutics, Inc. has experienced a more modest revenue journey. Starting with revenues just above $150,000 in 2014, the company saw a significant spike in 2023, reaching approximately $234 million. This surge, a staggering 153,000% increase, highlights TG Therapeutics' potential breakthrough in the biotech sector.
These contrasting revenue paths reflect the diverse strategies and market conditions faced by these two companies, offering valuable insights for investors and industry analysts alike.
Revenue Insights: AstraZeneca PLC and Regeneron Pharmaceuticals, Inc. Performance Compared
Breaking Down Revenue Trends: Pfizer Inc. vs Regeneron Pharmaceuticals, Inc.
Comparing Revenue Performance: Regeneron Pharmaceuticals, Inc. or Alnylam Pharmaceuticals, Inc.?
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Genmab A/S
Comparing Revenue Performance: Regeneron Pharmaceuticals, Inc. or Amneal Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.: A Comprehensive Revenue Analysis
argenx SE and TG Therapeutics, Inc.: A Comprehensive Revenue Analysis
TG Therapeutics, Inc. vs Vericel Corporation: Examining Key Revenue Metrics
Revenue Showdown: TG Therapeutics, Inc. vs Dynavax Technologies Corporation
Revenue Showdown: TG Therapeutics, Inc. vs Travere Therapeutics, Inc.
Who Generates More Revenue? TG Therapeutics, Inc. or Celldex Therapeutics, Inc.